Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells

Journal of Pharmacological Sciences

Volumn 109, Issue 2, 2009, Pages 257-264

  Ishizawa, Keisuke ^a   Izawa Ishizawa, Yuki ^a   Ohnishi, Sachiyo ^a   Motobayashi, Yuki ^a   Kawazoe, Kazuyoshi ^a   Hamano, Shuichi ^a   Tsuchiya, Koichiro ^a   Tomita, Shuhei ^a   Minakuchi, Kazuo ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Migration; Platelet derived growth factor; Proliferation; Quercetin glucuronide; Vascular smooth muscle cell

Indexed keywords

ACETYLCYSTEINE; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; QUERCETIN 3 O BETA DEXTRO GLUCURONIDE; QUERCETIN DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANTIOXIDANT; DRUG DERIVATIVE; GLUCURONIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; MALE; NONHUMAN; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GLUCURONIDES; MALE; MAP KINASE KINASE 4; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 65449157258     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08236FP     Document Type: Article

References (40)

1. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995;33:1061-1080.
2. Perez-Vizcaino F, Bishop-Bailley D, Lodi F, Duarte J, Cogolludo A, Moreno L, et al. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun. 2006;346:919-925.
3. Bucki R, Pastore JJ, Giraud F, Sulpice JC, Janmey PA. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis. J Thromb Haemost. 2003;1:1820-1828.
4. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med. 1994;16:845-850.
5. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, et al. Reduced progression of atherosclerosis in apolipo- protein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol. 1997;17:2744-2752.
6. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3- kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol. 2001;60:656-665.
7. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 1995;62:1276-1282.
8. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, et al. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 1997;418:152-156.
9. Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 1998;426:331-336.
10. Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol. 2000;279:R461-467.
11. Moon J, Tsushida T, Nakahara K, Terao J. Identification of quercetin 3-0-/?-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med. 2001;30:1274-1285.
12. Manach C, Texier O, Regerat F, Agullo G, Demigne C, Remesy C. Dietary quercetin is recovered in rat plasma as conjugated derivertives of isorhamnetin and quercetin. Nutr Biochem. 1996;7:375-380.
13. da Silva EL, Piskula MK, Yamamoto N, Moon JH, Terao J. Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett. 1998;430:405-408.
14. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, et al. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun. 2002;293:1458-1465.
15. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
16. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005;85:9-23.
17. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol. 2005;90:449-455.
18. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res. 1999; 85:1179-1185.
19. Kishi K, Muramatsu M, Jin D, Furubayashi K, Takai S, Tamai H, et al. The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs. Hypertens Res. 2007;30:77-83.
20. Yamamoto Y, Ogino K, Igawa G, Matsuura T, Kaetsu Y, Sugihara S, et al. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Hypertens Res. 2006;29:915-921.
21. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA. 1981;78:3669-3672.
22. Nakagawa M, Ohno T, Maruyama R, Okubo M, Nagatsu A, Inoue M, et al. Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. Biol Pharm Bull. 2007;30:1754-1757.
23. Izawa Y, Yoshizumi M, Ishizawa K, Fujita Y, Kondo S, Kagami S, et al. Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet- derived growth factor (PDGF)-induced vascular smooth muscle cell migration. Hypertens Res. 2007;30:1107-1117.
24. Bilato C, Pauly RR, Melillo G, Monticone R, Gorelick-Feldman D, Gluzband YA, et al. Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor. J Clin Invest. 1995;96:1905-1915.
25. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 2003;23:795-801.
26. Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, et al. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension. 2005;46:1046-1052.
27. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, et al. Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res. 2004;27:433-440.
28. Fujita Y, Yoshizumi M, Izawa Y, Ali N, Ohnishi H, Kanematsu Y, et al. Transactivation of fetal liver kinase-1 /kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation. Endocrinology. 2006;147: 1377-1385.
29. Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, et al. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1 /2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol. 2004;65:832-841.
30. Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res. 2005;39:185-194.
31. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem. 2008;283:9424-9434.
32. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, et al. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species- dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res. 2004;94:1219-1226.
33. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res. 2006;71:331-341.
34. Kappert K, Sparwel J, Sandin A, Seiler A, Siebolts U, Leppanen O, et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol. 2006;26:2644-2651.
35. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and Cas mediate JNK activation but not ERK1 /2 and p38 kinases by reactive oxygen species. J Biol Chem. 2000;275:11706-11712.
36. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000;20: 2175-2183.
37. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1 /2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res. 2001;24:251-261.
38. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999;274:22699-22704.
39. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med. 1997;22:749-760.
40. van Acker SA, van den Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med. 1996;20:331-342.